Skip to main content

FDA clears Vivos Therapeutics' oral device for sleep apnea

By Reuters  
   November 30, 2023

Vivos Therapeutics says the FDA has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.

Full story

Get the latest on healthcare leadership in your inbox.